Prof. Dr. med. Matthias Laudes

L. Henneke, K. Schlicht, N. Andreani, T. Hollstein, T. Demetrowitsch, C. Knappe, K. Hartmann, J. Jensen-Kroll, N. Rohmann, D. Pohlschneider, C. Geisler, D. Schulte, U. Settgast, K. Türk, J. Zimmermann, C. Kaleta, J. Baines, J. Shearer, S. Shah, G. Shen-Tu, K. Schwarz, A. Franke, S. Schreiber, and M. Laudes,
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes, Gut Microbes , vol. 14, no. 1, pp. 2057778, 2022.

DOI:	10.1080/19490976.2022.2057778

N. Rohmann, P. Stürmer, C. Geisler, K. Schlicht, K. Hartmann, K. Türk, T. Hollstein, F. Tran, P. Rosenstiel, A. Franke, J. Heyckendorf, S. Schreiber, D. Schulte, and M. Laudes,
Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection, Frontiers in Immunology , vol. 13, 2022.

DOI:	10.3389/fimmu.2022.1037115

C. Geisler, K. Schlicht, C. Knappe, N. Rohmann, K. Hartmann, K. Turk, U. Settgast, D. Schulte, T. Demetrowitsch, J. Jensen-Kroll, A. Pisarevskaja, F. Brix, B. Gruber, G. Rimbach, F. Doring, P. Rosenstiel, A. Franke, S. Schreiber, C. Henning, W. Lieb, U. Nothlings, K. Schwarz, and M. Laudes,
Cohort profile: the Food Chain Plus (FoCus) cohort, Eur J Epidemiol , vol. 37, no. 10, pp. 1087-1105, 2022.

DOI:	10.1007/s10654-022-00924-y

N. Rohmann, L. Munthe, K. Schlicht, C. Geisler, T. Demetrowitsch, C. Bang, J. Jensen-Kroll, K. Türk, P. Bacher, A. Franke, K. Schwarz, D. Schulte, and M. Laudes,
Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies, Nutrients , vol. 14, no. 11, pp. 2351, 2022.

C. Geisler, J. Pankoke, K. Schlicht, C. Knappe, N. Rohmann, K. Hartmann, U. Settgast, K. Türk, A. Seoudy, A. Franke, S. Schreiber, D. Schulte, and M. Laudes,
BMI, Alcohol Consumption and Gut Microbiome Species Richness Are Related to Structural and Functional Neurological Abnormalities, Nutrients , vol. 13, no. 11, pp. 3743, 2021.

D. Fangmann, C. Geisler, K. Schlicht, K. Hartmann, J. Köpke, A. Tiede, U. Settgast, K. Türk, D. Schulte, K. Altmann, I. Clawin-Rädecker, P. Lorenzen, S. Schreiber, K. Schwarz, and M. Laudes,
Differential effects of protein intake versus intake of a defined oligopeptide on FGF-21 in obese human subjects <em>in&#xa0;vivo</em>, Clinical Nutrition , vol. 40, no. 2, pp. 600-607, 2021.

DOI:	10.1016/j.clnu.2020.06.006

T. Hollstein, D. Schulte, J. Schulz, A. Glück, A. Ziegler, E. Bonifacio, M. Wendorff, A. Franke, S. Schreiber, S. Bornstein, and M. Laudes,
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report, Nature Metabolism , vol. 2, no. 10, pp. 1021-1024, 2020.

DOI:	10.1038/s42255-020-00281-8

N. Rohmann, K. Schlicht, C. Geisler, T. Hollstein, C. Knappe, L. Krause, S. Hagen, A. Beckmann, A. Seoudy, P. Wietzke-Braun, K. Hartmann, D. Schulte, K. Türk, J. Beckmann, W. Schönfels, F. Hägele, A. Bosy-Westphal, A. Franke, S. Schreiber, and M. Laudes,
Circulating sDPP-4 is Increased in Obesity and Insulin Resistance but Is Not Related to Systemic Metabolic Inflammation, The Journal of Clinical Endocrinology & Metabolism , vol. 106, no. 2, pp. e592-e601, 2020.

DOI:	10.1210/clinem/dgaa758

C. Kreutzer, S. Peters, D. Schulte, D. Fangmann, K. Turk, S. Wolff, T. Eimeren, M. Ahrens, J. Beckmann, C. Schafmayer, T. Becker, T. Kerby, A. Rohr, C. Riedel, F. Heinsen, F. Degenhardt, A. Franke, P. Rosenstiel, N. Zubek, C. Henning, S. Freitag-Wolf, A. Dempfle, A. Psilopanagioti, H. Petrou-Papadaki, L. Lenk, O. Jansen, S. Schreiber, and M. Laudes,
Hypothalamic Inflammation in Human Obesity Is Mediated by Environmental and Genetic Factors, Diabetes , vol. 66, no. 9, pp. 2407-2415, 2017.

DOI:	10.2337/db17-0067

D. Fangmann, E. Theismann, K. Türk, D. Schulte, I. Relling, K. Hartmann, J. Keppler, J. Knipp, A. Rehman, F. Heinsen, A. Franke, L. Lenk, S. Freitag-Wolf, E. Appel, S. Gorb, C. Brenner, D. Seegert, G. Waetzig, P. Rosenstiel, S. Schreiber, K. Schwarz, and M. Laudes,
Targeted Microbiome Intervention by Microencapsulated Delayed-Release Niacin Beneficially Affects Insulin Sensitivity in Humans, Diabetes Care , vol. 41, no. 3, pp. 398-405, 2017.

DOI:	10.2337/dc17-1967